Oaklins Healthcare Year 2025

Highlights & Review

In 2025, Oaklins successfully advised on M&A transactions across the healthcare sector, spanning multiple subsectors:

  • Life Sciences: from CMOs and SMOs to pharmaceutical companies
  • Healthcare Providers: care facilities, hospitals and other healthcare service providers
  • MedTech: specialized suppliers, manufacturers and niche distributors
  • Healthcare Technology: from AI-based solutions for CROs to healthcare communication companies

Overall, Oaklins successfully completed 36 healthcare transactions in 2025, reflecting its long-standing experience and deep expertise in the sector.

Find more in our report Oaklins Transactions in the Healthcare Sector 2025 – Review and Highlights.

Subscribe to Healthcare News

We regularly publish industry news from the healthcare sector. Around four times a year, our M&A report analyses current developments in Life Sciences, MedTech, Contract Pharma, as well as Healthcare Providers & Services. Subscribe to our newsletter to receive in-depth insights into markets, trends, and our perspectives.

Your contact persons

Our healthcare experts are happy to help you assess market opportunities and answer your questions personally.

Oaklins d.zuerrer 829 weiss
David Zürrer Basel, Switzerland
Partner
View profile
Original oaklins m.henniger 02 weiss
Moritz Henniger Basel, Switzerland
Analyst
View profile

About Oaklins

United by a strong belief that we can achieve the extraordinary. Oaklins is a global team of 850+ financial advisory professionals in 40 countries providing M&A, growth equity, ECM, debt advisory and corporate finance services to support entrepreneurs, corporates and investors in reaching their goals.

Related Healthcare articles